Results 261 to 270 of about 2,704,025 (289)

Fever Inspiration: Precision Engineering for Safe and Systemic Immunotherapy

Advanced Science, EarlyView.
This review examines engineered fever therapy (EFT) as a novel cancer treatment, harnessing fever's immunomodulatory effects to enhance systemic immune responses. It explores molecular mechanisms, advances in nanotechnology‐driven thermal immunotherapy, and a bioengineered framework for precise, safe fever induction. The paper evaluates EFT's potential
Yang Li, Fulong Man, Jianwei Cheng, Li Chen, Yongyong Li, Haiqing Dong   +5 more
wiley   +1 more source

How the Latest Guidelines Are Changing the Diagnostic and Therapeutic Landscape of Arterial Hypertension. [PDF]

J Clin Med
Pastore MC, Carmona De Azevedo Bellagamba C, Liga R, Stefanini A, Durante M, D'Ascenzi F, Pedrinelli R, Cameli M.   +7 more
europepmc   +1 more source

Smart Semiconductors: An Overview of AZnOS (A= Ca, Sr, Ba) Based Phosphors, Multi‐Stimuli Responsive Luminescence, and Potential Application Prospects

Advanced Science, EarlyView.
This paper reviews the research progress of CaZnOS, SrZnOS, and BaZnOS‐based semiconductor phosphors in recent years, including their crystal structures, synthesis methods, and luminescent properties, as well as summarizes their potential applications. Finally, the challenges and opportunities for the research of these phosphors are also summarized and
Yanze Wang, Xianhui Zhang, Biyun Ren, Jingnan Zhang, Qi'an Zhang, Ziyi Fang, Mingzhi Wu, Leipeng Li, Yanmin Yang, Yixi Zhuang, Gongxun Bai, Jiulin Gan, Dengfeng Peng   +12 more
wiley   +1 more source

Interim analysis of prospective observational multicenter study of patients with hypertension and chronic kidney disease in the Russian Federation (PRIORITY-CKD)

Е. V. Shlyakhto, G. P. Arutyunov, М. М. Batyushin, S. V. Villevalde, Н. Э. Звартау, С. В. Недогода, Shilov Em, A. E. Soloveva, Е. А. Медведева, E. A. Zorina, Natalya Alexandrovna Molitvoslovova   +10 more
openalex   +2 more sources

Pre‐Existing Th1 Immunity Outperforms Age in Predicting Antibody Responses to SARS‐CoV‐2 Inactivated Vaccines

Advanced Science, EarlyView.
Challenging the focus on age, this study finds pre‐existing T helper 1 cells are the key biomarker for predicting antibody response to SARS‐CoV‐2 inactivated vaccines. In both mice and humans, high responders exhibited elevated baseline T helper 1 cells, which correlated with robust humoral immunity, offering crucial guidance for improving vaccine ...
Chanyuan Ye, Xiaoli Zhang, Lingfeng Qiu, Jia Ji, Jueqing Gu, Hongyu Jia, Yingfeng Lu, Jiyang Chen, Zelu Meng, Jiangshan Lian, Hangping Yao, Xun Zeng, Yida Yang   +12 more
wiley   +1 more source

Prevalence and risk factors of hypertension among clients seeking care at Selected Healthcare Facilities in Kenya. [PDF]

PLoS One
Shah J, Manji S, Smith C, Nambafu J, Ochola A, Barasa L, Amir F, Abdalla H, Jowi S, Mithi C, Patel R, Ali SK.   +11 more
europepmc   +1 more source

Enhancing Anti‐Tumor Effects of Engineered Extracellular Vesicles via Endocytosis Route Switching and Interferon Response Suppression

Advanced Science, EarlyView.
CD19‐293‐EV can switch the CD19 endocytosis pathway from clathrin‐mediated endocytosis to aggregation‐dependent endocytosis, leading to lysosomal degradation of the CD19/EVs complex. Degradation of the EVs leads to impairment in the IFN response and enhancement in EV uptake by target cells, creating a potent feedback cycle.
Zixuan Huang, Chaoqun Lu, Yixin Wang, Huajian Xian, Yuling Zheng, Ting Kang, Rufang Xiang, Shufeng Xie, Minghui Wang, Zeyi Li, Xiaoli Xia, Yaoyifu Yu, Wenjie Zhang, Huijian Zheng, Renyao Pan, Dan Li, Chunjun Zhao, Han Liu   +17 more
wiley   +1 more source

Hypertension Medication Recommendation via Synergistic and Selective Modeling of Heterogeneous Medical Entities: Development and Evaluation Study of a New Model.

JMIR Med Inform
Zhang K, Zhang Z, Liang Y, Wang W, Wang X.   +4 more
europepmc   +1 more source